Received Sep 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | UNK | F4AC3 | IM / LA |
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 793PT | IM / LA |
Pt was given another dose of Arexvy on 9/12/25, after previously getting one on 10/23/2023. To report, pt has had no known side effects from the vaccination. Pt made an appointment for another dose. RPh questioned why pt was getting one before the age of 75 and pt reported having severe lung disease putting her at increased risk. RPh did not go back far enough into her history to see the previous dose.
NKA